This webinar was recorded live on March 14, 2024.
It is available on demand through March 31, 2025.
Register above for access.
Description
Revisions to the CLIA proficiency testing regulations go into effect on July 11, 2024. They include 29 newly regulated analytes and tighter proficiency testing acceptable limits for many currently regulated analytes, along with changes to grading and reporting. These revisions will drive updates to the proficiency testing conducted by laboratories.
In this webinar, Dr. Bremansu Osa-Andrews discusses the upcoming changes and provides actionable steps laboratorians can take to prepare. Attendees will come away with a clear path to meet the new regulations. The presentation will be followed by live Q&A with Dr. Osa-Andrews.
Target Audience
This activity is designed for lab supervisors, lab directors (and/or assistant directors), lab managers (supervisory and/or non-supervisory), medical technologists, pathologists, fellows, residents, in-training individuals, and other laboratory professionals overseeing/conducting within this topic.
Learning Objectives
At the end of this session, participants will be able to:
- Summarize the CLIA Proficiency Testing Final Rule's historical aspects and other provisions.
- Describe the finalized requirements, including the Microbiology changes and the Non-Microbiology changes, total allowable error and other acceptable limits.
- Explain some applicable steps laboratorians can take to prepare for the upcoming CLIA regulatory changes.
Faculty
Bremansu Osa-Andrews, PhD, DABCC, NRCC
Clinical Assistant Professor of Pathology, Immunology and Laboratory Medicine, University of Florida
Medical Director of Core Lab Section- Chemistry, Urinalysis and Immunology, University of Florida
Gainesville, Florida, USA
Disclosures and Statement of Independence
The Association for Diagnostics & Laboratory Medicine (formerly AACC) is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments.
The following faculty reported financial relationships:
- Bremansu Osa-Andrews, PhD, DABCC, NRCC
- Honorarium/Expenses: QuidelOrtho
Content Validity
All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients; AND/OR all scientific research referred to or reported in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis.
Accreditation Statement
This activity is approved for 1.0 ACCENT® continuing education credits. Activity ID #4281. This activity was planned in accordance with ACCENT® Standards and Policies.
Successful Completion Statement
Verification of Participation certificates are provided to registered participants based on completion of the activity, in its entirety, and the activity evaluation. For questions regarding continuing education, please email [email protected].